Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Nurix Therapeutics, Inc. - Common stock (NQ:NRIX)

16.23 -0.65 (-3.85%)
Streaming Delayed Price Updated: 3:41 PM EDT, May 7, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 377,630
Open 16.81
Bid (Size) 16.19 (200)
Ask (Size) 16.22 (100)
Prev. Close 16.88
Today's Range 15.86 - 16.88
52wk Range 8.195 - 22.50
Shares Outstanding 47,147,781
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
A Nurix Therapeutics (NRIX) Insider Sold 5,394 Shares for $90,000 ↗
Nurix Therapeutics, a biotech innovator in targeted cancer therapies, reported a notable insider sale amid strong one-year stock gains. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Nurix Therapeutics Announces New Preclinical Data Highlighting Breadth of Targeted Protein Degradation Pipeline at AACR 2026
From Nurix Therapeutics, Inc.
Via GlobeNewswire

Performance

YTD
-10.1%
-10.1%
1 Month
+2.8%
+2.8%
3 Month
-1.9%
-1.9%
6 Month
+30.3%
+30.3%
1 Year
+68.3%
+68.3%

More News

Read More
News headline image
Nurix Therapeutics Announces Multiple Presentations Showcasing Depth of Research Pipeline and Scientific Leadership at the American Association for Cancer Research (AACR) 2026 Annual Meeting
From Nurix Therapeutics, Inc.
Via GlobeNewswire
News headline image
Nurix Stock Is Down 6% This Past Year, but One Biotech Fund Still Boosted Its Bet By $63 Million ↗
Via The Motley Fool
Nurix Therapeutics Inc (NASDAQ:NRIX) Reports Mixed Q4 2025 Results, Highlights Key Clinical Milestone ↗
Via Chartmill
Nurix Stock Falls After-Hours After Wider Q3 Loss; Oppenheimer Sees FDA Support For Bexo, Retail Buys The Dip ↗
Via Stocktwits
News headline image
Biotech-Focused Fund Adds $12 Million to Immunome Bet as Stock Surges 120% ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Investor Slashes $70 Million From Zymeworks as Stock Jumps 60% in a Year ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Biotech Investor Adds $3 Million to Krystal Biotech as Revenue Hits $389 Million in 2025 ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Biotech Fund Doubles Down With $49 Million Scholar Rock Buy as Shares Climb 26% ↗
Via The Motley Fool
Topics Regulatory Compliance
A Whole Watchlist of “Coiled Springs” (Found With One Simple ChartMill Screen) ↗
Via Chartmill
News headline image
Precision's Payoff: Targeted Therapies Drive $131B Solid Tumor Market Surge
From Equity Insider
Via GlobeNewswire
News headline image
13 Analysts Have This To Say About Nurix Therapeutics ↗
Via Benzinga
News headline image
Nurix Therapeutics (NASDAQ: NRIX) Stock Soars as Pivotal Phase 2 Study for Bexobrutideg Ignites Investor Confidence
Via MarketMinute
News headline image
Breaking Down Nurix Therapeutics: 5 Analysts Share Their Views ↗
Via Benzinga
News headline image
Nurix Therapeutics Posts Downbeat Q3 Results, Joins Orthopediatrics, Levi Strauss And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗
Via Benzinga
News headline image
Why Applied Digital Shares Are Trading Higher By Around 25%; Here Are 20 Stocks Moving Premarket ↗
Via Benzinga
News headline image
Levi Strauss, USANA Health Sciences And 3 Stocks To Watch Heading Into Friday ↗
Via Benzinga
News headline image
NURIX THERAPEUTICS INC (NASDAQ:NRIX) Misses Q3 2025 Estimates, Shares Drop ↗
Via Chartmill
News headline image
6 Analysts Assess Nurix Therapeutics: What You Need To Know ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
Via Benzinga
News headline image
Which stocks are moving after the closing bell on Thursday? ↗
Via Chartmill
News headline image
A Glimpse Into The Expert Outlook On Nurix Therapeutics Through 5 Analysts ↗
Via Benzinga
News headline image
Amazon To Rally Around 28%? Here Are 10 Top Analyst Forecasts For Thursday ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
Via Benzinga

Frequently Asked Questions

Is Nurix Therapeutics, Inc. - Common stock publicly traded?
Yes, Nurix Therapeutics, Inc. - Common stock is publicly traded.
What exchange does Nurix Therapeutics, Inc. - Common stock trade on?
Nurix Therapeutics, Inc. - Common stock trades on the Nasdaq Stock Market
What is the ticker symbol for Nurix Therapeutics, Inc. - Common stock?
The ticker symbol for Nurix Therapeutics, Inc. - Common stock is NRIX on the Nasdaq Stock Market
What is the current price of Nurix Therapeutics, Inc. - Common stock?
The current price of Nurix Therapeutics, Inc. - Common stock is 16.23
When was Nurix Therapeutics, Inc. - Common stock last traded?
The last trade of Nurix Therapeutics, Inc. - Common stock was at 05/07/26 03:41 PM ET
What is the market capitalization of Nurix Therapeutics, Inc. - Common stock?
The market capitalization of Nurix Therapeutics, Inc. - Common stock is 765.21M
How many shares of Nurix Therapeutics, Inc. - Common stock are outstanding?
Nurix Therapeutics, Inc. - Common stock has 765M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.